DGAT2 Plays a Crucial Role to Control ESRRAPROX1 Transcriptional Network to Maintain Hepatic Mitochondrial Sustainability

Background Diacylglycerol O-acyltransferase 2 (DGAT2) synthesizes triacylglycerol (TG) from diacylglycerol; therefore, DGAT2 is considered as a therapeutic target for steatosis. However, the consequence of inhibiting DGAT2 is not fully investigated due to side effects including lethality and lipotox...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yoseob Lee, Yeseong Hwang, Minki Kim, Hyeonuk Jeon, Seyeon Joo, Sungsoon Fang, Jae-Woo Kim
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Korean Diabetes Association 2024-09-01
סדרה:	Diabetes & Metabolism Journal
נושאים:	carcinoma, hepatocellular diacylglycerol o-acyltransferase mitochondria non-alcoholic fatty liver disease
גישה מקוונת:	http://www.e-dmj.org/upload/pdf/dmj-2023-0368.pdf
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!